(HealthDay)—A simple model may be used to predict risk for in-hospital adverse events among patients receiving an implantable cardioverter defibrillator (ICD), according to research published online Dec. ...
5 hours ago
not rated yet | 0
Johns Hopkins researchers say that a drug approved to treat lung cancer substantially shrank tumors in mice that were caused by a rare form of bone cancer called chordoma.
Dec 11, 2013
5 / 5 (1) | 0